Injectables and Facelifts: Can We Coexist? A Retrospective Chart Review Assessing Injectable Treatments Preceding and Following Rhytidectomy
Journal of Cosmetic Dermatology · 2026
DOI: 10.1111/jocd.70690 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cosmetic Dermatology, 2026. Verfasst von Bridget Myers und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, UC Davis, Sacramento, California, USA. Hauptthemen laut MEDLINE: Rhytidoplasty, Dermal Fillers. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Facelift surgery is a cornerstone of facial rejuvenation, yet it may not fully address volume loss, skin quality, or other age‐related changes. Minimally invasive procedures—such as injectables and energy‐based devices—are increasingly utilized before and after facelift surgery, though their impact on surgical outcomes remains uncertain.
Objective
The objective of this single‐center retrospective pilot study is to describe patterns of minimally invasive procedures among patients undergoing facelift surgery in a real‐world clinical setting and identify areas for future investigations regarding their potential influence on surgical outcomes.
Methods
We analyzed data from 20 patients who underwent facelift surgery and had a documented history of neurotoxin, filler, biostimulator, or energy‐based device treatment. Data included patient demographics, treatment history, surgical details, and post‐operative satisfaction. Given the limited sample size and retrospective design, the analyses done were descriptive and exploratory in nature.
Results
All patients received neurotoxin prior to facelift, 90% received hyaluronic‐acid filler, and 55% received poly‐L‐lactic acid or calcium hydroxylapatite. Following surgery, all patients resumed neurotoxin use, and 60% received filler treatments within the first post‐operative year. No reported significant surgical complications occurred because of prior filler or biostimulator treatments, and patient satisfaction was high for facelift outcomes.
Conclusion
Within our small, retrospective cohort, prior injectable or energy‐based device use was not associated with an increased risk of observable adverse surgical outcomes; however, the limited sample size precludes definitive assessment of safety or risk. Larger, prospectively designed studies are warranted to validate these early observations and optimally define best practices for combining surgical and nonsurgical rejuvenation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, UC Davis, Sacramento, California, USA.
- Cosmetic Laser Dermatology, San Diego, California, USA.
- Department of Otolaryngology, University of Illinois, Chicago, Illinois, USA.
ORCID-Profile: Bridget Myers
Zitieren
APA
Myers, B., Firsowicz, M., Kamrani, P., Dayan, S., & Fabi, S. (2026). Injectables and Facelifts: Can We Coexist? A Retrospective Chart Review Assessing Injectable Treatments Preceding and Following Rhytidectomy. Journal of Cosmetic Dermatology. https://doi.org/10.1111/jocd.70690
Vancouver
Myers B, Firsowicz M, Kamrani P, Dayan S, Fabi S. Injectables and Facelifts: Can We Coexist? A Retrospective Chart Review Assessing Injectable Treatments Preceding and Following Rhytidectomy. Journal of Cosmetic Dermatology. 2026. doi:10.1111/jocd.70690
BibTeX
@article{Myers2026,
author = {Myers, Bridget and Firsowicz, Maya and Kamrani, Payvand and Dayan, Steven and Fabi, Sabrina},
title = {Injectables and Facelifts: Can We Coexist? A Retrospective Chart Review Assessing Injectable Treatments Preceding and Following Rhytidectomy},
journal = {Journal of Cosmetic Dermatology},
year = {2026},
doi = {10.1111/jocd.70690}
}
EUVIMED